The aim of this study was to evaluate Tl-201 whole-body imaging in the
detection of metastases prior to surgery in patients with malignant m
elanoma. Whole-body imaging was performed in 30 patients with known or
suspected metastases 5 and 30 min after administration of 150 MBq Tl-
201. The imaging results were compared with the histopathological find
ings in each patient on a lesion-by-lesion basis. Of the 39 metastases
proven histopathologically, 34 were detected by Tl-201 imaging (sensi
tivity = 87%), including 4 in-transit metastases and one inguinal lymp
h node metastasis which were unknown prior to investigation. Due to th
ese additional findings on Tl-201 imaging, scheduled surgical therapy
was changed in three patients. Tl-201 imaging was false-negative in fo
ur lymph node metastases and one skin lesion, and there were two false
-positive Tl-201 scans with tracer accumulation in inflammatory sites.
The mean target-to-background ratio on the true-positive scans was 1.
72 +/- 0.37 and 1.67 +/- 0.41 (P > 0.05) at 5 and 30 min post-injectio
n respectively In conclusion, Tl-201 whole-body imaging appears sensit
ive and simple to perform in the detection of metastases prior to surg
ery in melanoma patients.